DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Paz-Priel I. , Chang T, Asikanius E, et al.
Immunogenicity of emicizumab in people with hemophiliaA (PwHA): results from the HAVEN 1–4 studies.
Blood 2018;
132 (Suppl. 01) 633-633
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.